Home Cart 0 Sign in  
X

[ CAS No. 6282-88-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 6282-88-8
Chemical Structure| 6282-88-8
Chemical Structure| 6282-88-8
Structure of 6282-88-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6282-88-8 ]

Related Doc. of [ 6282-88-8 ]

Alternatived Products of [ 6282-88-8 ]

Product Details of [ 6282-88-8 ]

CAS No. :6282-88-8 MDL No. :MFCD00831102
Formula : C9H11ClO Boiling Point : -
Linear Structure Formula :- InChI Key :ZHBIWFGGIKFSHZ-UHFFFAOYSA-N
M.W : 170.64 Pubchem ID :221971
Synonyms :

Calculated chemistry of [ 6282-88-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.19
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.22
Log Po/w (XLOGP3) : 2.23
Log Po/w (WLOGP) : 2.26
Log Po/w (MLOGP) : 2.76
Log Po/w (SILICOS-IT) : 2.98
Consensus Log Po/w : 2.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.51
Solubility : 0.529 mg/ml ; 0.0031 mol/l
Class : Soluble
Log S (Ali) : -2.29
Solubility : 0.875 mg/ml ; 0.00513 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.65
Solubility : 0.0385 mg/ml ; 0.000225 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.09

Safety of [ 6282-88-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6282-88-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6282-88-8 ]
  • Downstream synthetic route of [ 6282-88-8 ]

[ 6282-88-8 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 2019-34-3 ]
  • [ 6282-88-8 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; Inert atmosphere
Stage #2: With Rochelle's salt In tetrahydrofuran at 0 - 20℃;
Preparation of 3-(4-chlorophenvDpropan-l-ol A slurry of LAH (2.10 g, 55.2 mmol) in dry THF (250 mL) is stirred at 0 °C under nitrogen and a solution of 3-(4-chlorophenyl)propionic acid (10.2 g, 55.2 mmol) in THF (10 mL) is added slowly. The reaction is allowed to warm to rt and stirred overnight. The reaction is cooled at 0 °C and a saturated solution of potassium sodium tartrate (20 mL) is added carefully. The mixture is then stirred at rt for 4 h, diluted with ethyl acetate and filtered through Celite. The salts are washed with ethyl acetate and the filtrate is concentrated to give 9.20 g (97percent) of desired product as clear colorless oil. NMR (400 MHz, CDC ) δ 1.89 (2 H, m), 2.71 (2 H, m), 3.69 (2 H, t,), 7.15 (2 H, d,), 7.27 (2 H, d); HPLC retention time: 3.44 min. (Method A).
Reference: [1] Patent: WO2011/126567, 2011, A1, . Location in patent: Page/Page column 163-164
[2] Organic Letters, 2012, vol. 14, # 3, p. 840 - 843
[3] Journal of the American Chemical Society, 2003, vol. 125, # 23, p. 6977 - 6985
[4] Patent: US2003/158177, 2003, A1,
[5] Patent: US2002/58660, 2002, A1,
[6] Patent: US4489094, 1984, A,
[7] Patent: US4489094, 1984, A,
[8] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 8, p. 2426 - 2431
[9] Journal of Medicinal Chemistry, 2013, vol. 56, # 23, p. 9427 - 9440
[10] Journal of the American Chemical Society, 2015, vol. 137, # 12, p. 4010 - 4013
  • 2
  • [ 1615-02-7 ]
  • [ 6282-88-8 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran for 12 h; Inert atmosphere; Cooling with ice; Reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 0 - 20℃; for 0.5 h;
9.1 3-(4-Chloro-phenyl)-propan-1-olTo a suspension of lithium aluminium hydride (20.26 g, 37.95 mmol) in THF (tetrahy- drofuran) (300 mL) under nitrogen atmosphere was slowly added a solution of 3-(4- chloro-phenyl)-acrylic acid (65.00 g, 355.96 mmol) in THF (500 mL) under cooling with an ice bath. The resulting mixture was stirred until it reached room temperature and then refluxed for 12 h. After cooling to room temperature, a 10percent HCI solution was added at 0° C and the resultant solution was stirred for 0.5 h. The mixture was then extracted with MTBE (methyl tert-butyl ether) and the organic layers were washed with water, dried and evaporated. The title compound was obtained as a brown oil (70.0 g, 98percent).
Reference: [1] Patent: WO2010/146111, 2010, A1, . Location in patent: Page/Page column 113-114
[2] Organic Letters, 2012, vol. 14, # 17, p. 4394 - 4397
[3] Tetrahedron Letters, 2015, vol. 56, # 8, p. 1045 - 1048
  • 3
  • [ 637-87-6 ]
  • [ 107-18-6 ]
  • [ 6282-88-8 ]
  • [ 59667-21-9 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With sodium hydrogencarbonate In DMF (N,N-dimethyl-formamide) at 50℃; for 7 h;
Stage #2: With sodium tetrahydroborate In DMF (N,N-dimethyl-formamide) at 5℃; for 0.5 h;
EXAMPLE 1Pd Coupling Reaction and Reduction of Aldehyde 95.38 g (400 mmol) of p-chloroiodobenzene, 34.85 g (600 mmol) of ally alcohol, 0.089 g (0.4 mmol) of palladium acetate and 47.99 g (2,000 mmol) of sodium hydrogencarbonate, were added to 200 ml of dimethylformamide (DMF), followed by heating until the internal temperature of the suspension became 50° C. The heating was continued for 7 hours, and after confirming the formation of the aldehyde compound by gas chromatogram, the suspension was cooled to 5° C. Then, 4.54 g (120 mmol) of sodium borohydride was added, followed by stirring for 30 minutes. Then, 100 ml of a saturated ammonium chloride aqueous solution, 100 ml of water and 200 ml of toluene were added, followed by stirring for one hour. After removing insolubles by Celite filtration, liquid separation was carried out, and the water layer was extracted again with 200 ml of toluene. The tolune layers were put together, concentrated and then distilled (107° C./1 mmHg) to obtain 63.4 g (y 93percent) of 3-(p-chlorophenyl)-1-propanol {compound (1)} as a colorless oily substance. From the analysis by gas chromatography, this product was found to contain 6percent of the branched isomer.
Reference: [1] Patent: US6407298, 2002, B1, . Location in patent: Page column 5
  • 4
  • [ 1615-02-7 ]
  • [ 6282-88-8 ]
YieldReaction ConditionsOperation in experiment
54.7%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; Inert atmosphere; Cooling with ice
Stage #2: for 4 h; Reflux; Inert atmosphere
Yield: 23.3-88.0percent .Take 3-(4-chlorophenyl)propan-1-ol (3c) for example. To a suspension of lithium aluminum hydride (1.71 g, 45 mmol) in THF (30 mL), under nitrogen atmosphere and ice bath, the solution of 2.74 g (15 mmol) 3-(4-chlorophenyl)acrylic acid (2c) in THF was gently added in 30 min. the resulting mixture stirred until it reached ambient temperature and then it was reflux for 4h. When TLC analyses indicated the disappearance of the starting material, after cooling to ambient temperature, 15 ml methanol and 15 ml water was dropped slowly to quench the reaction, then the PH was adjusted to 3 with 10percent hydrochloric acid, The crude mixture was extracted with ethyl acetate (3 × 30 ml), organic layer was combined and dried over anhydrous MgSO4 and concentrated in vacuo. The resulting yellow oil was purified by chromatography on silica-gel column (n-hexane: ethyl acetate = 4:1, v/v) to obtain the product, yellow oil, yield 54.7percent. 1H NMR (300 MHz, CDCl3) δ: 7.27-7.22(m, 2H), 7.15-7.10 (m, 2H), 3.66(t, J=6.4Hz, 2H), 2.68(t, J=7.44Hz, 2H), 1.91-1.81(m, 2H).
54.7% With lithium aluminium tetrahydride In tetrahydrofuran for 4.5 h; Inert atmosphere; Reflux; Cooling with ice General procedure: To a suspension of lithium aluminum hydride (1.71g, 45mmol) in THF (30mL), under nitrogen atmosphere and ice bath, the solution of 15mmol 3-(4-substituted phenyl)acrylic acid (2a-h) in THF was gently added in 30min. the resulting mixture stirred until it reached ambient temperature and then it was reflux for 4h. When TLC analyses indicated the disappearance of the starting material, after cooling to ambient temperature, 15ml methanol and 15ml water was dropped slowly to quench the reaction, then the PH was adjusted to 3 with 10percent hydrochloric acid, The crude mixture was extracted with ethyl acetate (3×30 ml), organic layer was combined and dried over anhydrous MgSO4 and concentrated in vacuo. The resulting yellow oil was purified by chromatography on silica-gel column (n-hexane: ethyl acetate = 4:1, v/v) to obtain the product.
Reference: [1] Chinese Chemical Letters, 2016, vol. 27, # 4, p. 555 - 558
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 7, p. 1849 - 1853
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 18, p. 4752 - 4756
  • 5
  • [ 24393-52-0 ]
  • [ 6282-88-8 ]
Reference: [1] Synthesis, 2009, # 4, p. 660 - 664
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 18, p. 4752 - 4756
[3] European Journal of Organic Chemistry, 2006, # 20, p. 4573 - 4577
  • 6
  • [ 7116-36-1 ]
  • [ 6282-88-8 ]
Reference: [1] European Journal of Organic Chemistry, 2006, # 20, p. 4573 - 4577
[2] Bulletin of the Chemical Society of Japan, 1959, vol. 32, p. 1135,1136
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 18, p. 4752 - 4756
[4] Green Chemistry, 2018, vol. 20, # 14, p. 3191 - 3196
  • 7
  • [ 104-88-1 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 16, p. 3549 - 3557
[2] Journal of the Indian Chemical Society, 2013, vol. 90, # 10, p. 1853 - 1860
[3] Chinese Chemical Letters, 2016, vol. 27, # 4, p. 555 - 558
[4] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 7, p. 1849 - 1853
  • 8
  • [ 50561-69-8 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 12, p. 4010 - 4013
[2] Journal of Medicinal Chemistry, 2002, vol. 45, # 16, p. 3549 - 3557
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 23, p. 9427 - 9440
  • 9
  • [ 1075-77-0 ]
  • [ 6282-88-8 ]
  • [ 24583-70-8 ]
  • [ 75677-02-0 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 7, p. 2378 - 2381
[2] Journal of Organic Chemistry, 1998, vol. 63, # 7, p. 2378 - 2381
  • 10
  • [ 20754-21-6 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 16, p. 3549 - 3557
  • 11
  • [ 1073-67-2 ]
  • [ 201230-82-2 ]
  • [ 6282-88-8 ]
  • [ 59667-21-9 ]
Reference: [1] Journal of the Chemical Society, Chemical Communications, 1991, # 4, p. 233 - 234
  • 12
  • [ 64-17-5 ]
  • [ 6282-88-8 ]
  • [ 50561-69-8 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 9, p. 1657 - 1660
  • 13
  • [ 1073-67-2 ]
  • [ 50-00-0 ]
  • [ 6282-88-8 ]
  • [ 59667-21-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 16, p. 4632 - 4636
  • 14
  • [ 24583-70-8 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of the Indian Chemical Society, 2013, vol. 90, # 10, p. 1853 - 1860
  • 15
  • [ 1615-02-7 ]
  • [ 6282-88-8 ]
  • [ 24583-70-8 ]
Reference: [1] Synthesis, 2011, # 9, p. 1375 - 1382
  • 16
  • [ 6048-06-2 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of the Indian Chemical Society, 2013, vol. 90, # 10, p. 1853 - 1860
  • 17
  • [ 37556-13-1 ]
  • [ 6282-88-8 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 14, p. 3191 - 3196
  • 18
  • [ 6529-53-9 ]
  • [ 6282-88-8 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 14, p. 3191 - 3196
  • 19
  • [ 75-21-8 ]
  • [ 104-83-6 ]
  • [ 6282-88-8 ]
Reference: [1] Journal of the Chemical Society, 1964, p. 1548 - 1553
  • 20
  • [ 6282-88-8 ]
  • [ 64473-35-4 ]
YieldReaction ConditionsOperation in experiment
97% With bromine; triphenylphosphine In dichloromethane at 0 - 20℃; Preparation of l-(3-bromopropyl)-4-chlorobenzeneA solution of triphenylphosphine (7.42 g, 28.3 mmol) in DCM (200 mL) is cooled at 0 °C and a solution of bromine (1.46 mL, 28.3 mmol) in DCM (40 mL) is added slowly over a period of 30 min. A solution of 3-(4-chlorophenyl)propan-l-ol (4.6 g, 27 mmol) in DCM (20 mL) is then added and the reaction is allowed to warm to rt and stir for 24 h. The reaction mixture is then transferred to a separatory funnel; washed with saturated sodium bicarbonate, water and brine; and the organics are dried with anhydrous sodium sulfate and concentrated. The residue is subjected to silica gel chromatography (230-400 mesh, 350 g, elution with 7.5 percent ethyl acetate/hexane) to give 6.15 g (97percent) of the desired product as clear colorless oil. NMR (400 MHz, CDC13) δ 2.16 (2 H, m), 2.77 (2 H, t), 3.41 (2 H, t), 7.15 (2 H, d), 7.27 (2 H, d); HPLC retention time: 5.1 1 min. (Method A).
83% With phosphorus tribromide In toluene at 20 - 90℃; for 3 h; EXAMPLE 2
Bromination
66.0 g (387 mmol) of 3-(p-chlorophenyl)-1-propanol was dissolved in 350 ml of toluene, and a solution having 105 g (387 mmol) of phosphorus tribromide dissolved in 50 ml of toluene, was dropwise added thereto..
After the dropwise addition, the internal temperature of the reaction solution was raised to 90° C. and returned to room temperature 3 hours later.
250 ml of a 1N sodium hydroxide aqueous solution was added thereto, followed by shaking..
Then, the solution was left to stand still for liquid separation, and the water layer was extracted again with 150 ml of toluene..
The toluene layers were put together and washed with 150 ml of a saturated sodium chloride aqueous solution, followed by Celite filtration, and then the solvent was distilled off..
The residue was Idistilled to obtain 75.2 g (y 83percent) of the desired 3-(p-chlorophenyl)-1-propyl bromide {compound (2)) as a colorless oily substance (85-89° C./0.3 MmHg)
35% With hydrogen bromide In water at 20℃; for 2 h; 9.2 1-(3-Bromo-propyl)-4-chloro-benzene3-(4-Chloro-phenyl)-propan-1-ol of step 9.1 (59.0 g, 170 mmol) was added to a solution of 47percent aqueous HBr (295 ml.) and the resulting mixture was stirred at room temperature for 2 h. Water was added and the mixture was extracted with CH2CI2. The com- bined organic phases were washed with water, dried and evaporated. The crude residue was purified by flash chromatography on silica gel to give the title compound as a brown oil (28.1 g, 35percent).
Reference: [1] Patent: WO2011/126567, 2011, A1, . Location in patent: Page/Page column 164
[2] Patent: US6407298, 2002, B1, . Location in patent: Page column 5
[3] Patent: WO2010/146111, 2010, A1, . Location in patent: Page/Page column 114
[4] Journal of Medicinal Chemistry, 2002, vol. 45, # 16, p. 3549 - 3557
[5] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 18, p. 4752 - 4756
[6] Patent: EP2168944, 2010, A1, . Location in patent: Page/Page column 71
[7] Green Chemistry, 2018, vol. 20, # 14, p. 3191 - 3196
  • 21
  • [ 6282-88-8 ]
  • [ 558-13-4 ]
  • [ 64473-35-4 ]
YieldReaction ConditionsOperation in experiment
100% With triphenylphosphine In dichloromethane at 0 - 20℃; Example 502-[3-(4-chlorophenyl)propyl]-N-hydroxy-1-oxo-1,2-dihydroisoquinoline-7-carboxamide Compound I-131 Step 1: 1-(3-bromopropyl)-4-chlorobenzeneTo a solution of 3-(4-chlorophenyl)propan-1-ol (0.25 g, 1.46 mmol) in dichloromethane (5.5 mL) cooled at 0° C. was added triphenylphosphine (0.42 g, 1.6 mmol) and carbon tetrabromide (0.51 g, 1.5 mmol) and the reaction was stirred at rt overnight. The reaction was quenched with water and extracted with DCM (2.x.). The combined organic phases were then washed with water, and brine, dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash silica gel chromatography (0percent to 70percent EtOAc/hexanes) to afford 1-(3-bromopropyl)-4-chlorobenzene (0.34 g, quant.). LC-MS: (FA) ES+234.
Reference: [1] Patent: US2012/94997, 2012, A1, . Location in patent: Page/Page column 95
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6282-88-8 ]

Aryls

Chemical Structure| 5182-44-5

[ 5182-44-5 ]

2-(3-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 1875-88-3

[ 1875-88-3 ]

2-(4-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 35364-79-5

[ 35364-79-5 ]

2-(3,4-Dichlorophenyl)ethanol

Similarity: 0.89

Chemical Structure| 5468-97-3

[ 5468-97-3 ]

1-(4-Chlorophenyl)-2-methylpropan-2-ol

Similarity: 0.86

Chemical Structure| 831-81-2

[ 831-81-2 ]

4-Chlorodiphenylmethane

Similarity: 0.85

Chlorides

Chemical Structure| 5182-44-5

[ 5182-44-5 ]

2-(3-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 1875-88-3

[ 1875-88-3 ]

2-(4-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 35364-79-5

[ 35364-79-5 ]

2-(3,4-Dichlorophenyl)ethanol

Similarity: 0.89

Chemical Structure| 5468-97-3

[ 5468-97-3 ]

1-(4-Chlorophenyl)-2-methylpropan-2-ol

Similarity: 0.86

Chemical Structure| 831-81-2

[ 831-81-2 ]

4-Chlorodiphenylmethane

Similarity: 0.85

Alcohols

Chemical Structure| 5182-44-5

[ 5182-44-5 ]

2-(3-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 1875-88-3

[ 1875-88-3 ]

2-(4-Chlorophenyl)ethanol

Similarity: 0.94

Chemical Structure| 35364-79-5

[ 35364-79-5 ]

2-(3,4-Dichlorophenyl)ethanol

Similarity: 0.89

Chemical Structure| 5468-97-3

[ 5468-97-3 ]

1-(4-Chlorophenyl)-2-methylpropan-2-ol

Similarity: 0.86

Chemical Structure| 1875-87-2

[ 1875-87-2 ]

2-(2,5-Dichlorophenyl)ethan-1-ol

Similarity: 0.84